Status:
COMPLETED
Acceptance and Commitment Therapy for Patients With Chronic Heart Failure and Their Caregivers on Their Quality of Life
Lead Sponsor:
The Hong Kong Polytechnic University
Conditions:
Chronic Heart Failure
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study is to examine whether group-based Acceptance and Commitment Therapy in the patient-caregiver dyads with Chronic Heart Failure is effective in improving dyadic health-related quality of life...
Detailed Description
Chronic heart failure (CHF) is a complex progressive debilitating illness characterized by high morbidity and mortality with unpredictable course and frequent hospital readmissions. Patients with CHF ...
Eligibility Criteria
Inclusion
- Patient-caregiver dyads will be recruited as units if both are eligible as listed below.
- Patient
- 18 years or older
- a confirmed diagnosis of Chronic Heart Failure (CHF) according to international guidelines
- with New York Heart Association (NYHA) functional classification I to III
- has been hospitalized in the past one year
- able to nominate a primary family caregiver (if two or more family members where the primary caregivers of the patient, the one who had the highest average contact hours with the patient)
- can understand and communicate in Chinese
- can access Tencent VooV Meeting via smartphone for attending the intervention
Exclusion
- has a documented medical history of psychiatric illness, dementia, and life-threatening, such as end-stage renal failure, severe pulmonary disease and respiratory disease
- has cognitive impairment evaluated with a score of 0-2 on the Mini-Cog scale
- living in a nursing home
- Caregiver
- Inclusion Criteria:
- 18 years or older
- can understand and communicate in Chinese
- have been providing care to the patient for more than 14 hours per week for at least three consecutive months
- can access Tencent VooV Meeting via smartphone for attending the intervention
Key Trial Info
Start Date :
June 10 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 14 2023
Estimated Enrollment :
362 Patients enrolled
Trial Details
Trial ID
NCT04917159
Start Date
June 10 2022
End Date
September 14 2023
Last Update
August 29 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Taihe Hospital
Shiyan, Hubei, China, 430000